Quest Diagnostics Incorporated, the world’s leader in cancer diagnostics, announced today that the company has received CEO Cancer Gold Standard accreditationTM from The CEO Roundtable on Cancer. This prestigious designation recognizes Quest Diagnostics for taking important actions to reduce the cancer risk of its employees and their families.
Read more about this recognition and what Quest Diagnostics is doing to aide in the fight against cancer.
For more information about drug testing, visit our website or contact us online.
59 comments on “CEO roundtable for cancer honor”